Exogenous Surfactant Administration by Asymmetric High-Frequency Jet Ventilation in Experimental Respiratory Distress Syndrome

Calkovska, Andrea; Sevecova-Mokra, Daniela; Javorka, Kamil; Petraskova, Maria; Adamicova, Katarina
April 2005
Croatian Medical Journal;2005, Vol. 46 Issue 2, p209
Academic Journal
Evaluates the efficacy of surfactant administration using the instillation technique by means of asymmetric high-frequency jet ventilation in experimental respiratory distress syndrome. Indications of surfactant therapy in newborns with respiratory distress syndrome; Methodology of the study; Discussion on the results of the study.


Related Articles

  • Normocapnic High-frequency Oscillatory Ventilation Affects Differently Extrapulmonary and Pulmonary Forms of Acute Respiratory Distress Syndrome in Adults. Pachl, J.; Roubík, K.; Waldauf, P.; Fric, M.; Zábrodský, V. // Physiological Research;2006, Vol. 55 Issue 1, p15 

    The recently reported differences between pulmonary and extrapulmonary acute respiratory distress syndromes (ARDSp, ARDSexp) are the main reasons of scientific discussion on potential differences in the effects of current ventilatory strategies. The aim of this study is to assess whether the...

  • Bench performance of ventilators during simulated paediatric ventilation. PARK, M. A. J.; FREEBAIRN, R. C.; GOMERSALL, C. D. // Anaesthesia & Intensive Care;May2013, Vol. 41 Issue 3, p349 

    The article compares the accuracy and capabilities of different ventilators using a paediatric acute respiratory distress syndrome lung model. Findings reveal that none of the ventilators could consistently deliver tidal volumes within 1 ml/kg of the set tidal volume, and the discrepancy between...

  • Immediate Changes in Lung Compliance Following Natural Surfactant Administration in Premature Infants with Respiratory Distress Syndrome: a Controlled Trial. Attar, Mohammad A.; Becker, Michael A.; Dechert, Ronald E.; Donn, Steven M. // Journal of Perinatology;Oct2004, Vol. 24 Issue 10, p626 

    OBJECTIVE: To compare immediate changes in lung compliance following the administration of two commercially available natural surfactants. METHOD: We conducted a prospective, randomized study of 40 preterm infants with respiratory distress syndrome requiring surfactant. Infants received either...

  • Is Surfactant a Promising Additive Drug in ALI / ARDS-Patients? Schultz, Marcus J.; Kesecioglu, Jozef // Current Drug Targets;Jul2004, Vol. 5 Issue 5, p445 

    The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the...

  • Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Möller, Jens Christian; Schaible, Thomas; Roll, Claudia; Schiffmann, Jan-Holger; Bindl, Lutz; Schrod, Lothar; Reiss, Irwin; Kohl, Martina; Demirakca, Subha; Hentschel, Roland; Paul, Thomas; Vierzig, Anne; Groneck, Peter; von Seefeld, Heide; Schumacher, Helmut; Gortner, Ludwig; Möller, Jens Christian; Surfactant ARDS Study Group // Intensive Care Medicine;Mar2003, Vol. 29 Issue 3, p437 

    Objective. To determine whether bovine surfactant given in cases of severe pediatric acute respiratory distress syndrome (ARDS) improves oxygenation. Design. Single-center study with 19 patients, followed by a multicenter randomized comparison of surfactant with a standardized treatment...

  • A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome. Walti, H.; Monset-Couchard, M. // Drug Safety;May1998, Vol. 18 Issue 5, p321 

    Alveolar surfactant is central to pulmonary physiology. Quantitative and qualitative surfactant abnormalities appear to be the primary aetiological factors in neonatal respiratory distress syndrome (RDS) and exogenous replacement of surfactant is a rational treatment. Available exogenous...

  • Pulmonary surfactant: functions, abnormalities and therapeutic options. Frerking, Ilka; Günther, Andreas; Seeger, Werner; Pison, Ulrich // Intensive Care Medicine;Nov2001, Vol. 27 Issue 11, p1699 

    The first successful clinical pilot studies of surfactant replacement were published about 20 years ago as a logical extension of experimental studies showing beneficial effects in pre-term animals. The efficacy of this therapy for immature new-borns has been confirmed in various controlled...

  • A natural surfactant from pig lungs. Kubrusly, Flàvia S.; de Lima Netto, Solange; Iourtov, Dmitri; Raw, Isaias; de Araujo, Pedro Soares // Biotechnology Letters;Aug2000, Vol. 22 Issue 15, p1251 

    An exogenous natural lung surfactant obtained from minced pig lungs can be produced by a technology using a low cost, DEAE-cellulose adsorbent. This surfactant is composed mainly with phospholipids and the two hydrophobic polypeptides, SP-B and SP-C, both of which are necessary for optimal...

  • Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome. Köksal, Nilgün; Akpınar, Reyhan; Çetinkaya, Merih // Turkish Journal of Pediatrics;Nov/Dec2009, Vol. 51 Issue 6, p556 

    The aim of this study was to determine whether early administration (2 hours after the first surfactant dose) of the second surfactant dose would be superior to late surfactant treatment (6 hours after the first surfactant dose) in preterm infants with severe respiratory distress syndrome....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics